Paradigm Biocapital Advisors LP

13F Portfolio Filings

Most recent 13F
Q2 2024
Location
New York, NY
CIK
0001855655
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2024 35 2,613,016 NUVL, ARGX, ACLX, RVMD 13F-HR 8/14/2024 000185565524000009
Q1 2024 34 2,840,751 NUVL, ACLX, ARGX, IRON 13F-HR 5/15/2024 000185565524000005
Q4 2023 30 2,135,928 NUVL, ACLX, ARGX, IRON 13F-HR 2/14/2024 000185565524000002
Q3 2023 31 1,473,652 LEGN, ARGX, ACLX, OLMA 13F-HR 11/14/2023 000185565523000011
Q2 2023 30 1,294,170 LEGN, INCY, IMCR, ACLX 13F-HR 8/14/2023 000185565523000008
Q1 2023 25 1,055,174 BIIB, INCY, LEGN, ARGX 13F-HR 5/15/2023 000185565523000006
Q4 2022 23 851,901 INCY, BIIB, MRTX, HZNP 13F-HR 2/14/2023 000185565523000003
Q3 2022 28 750,139 GLOBAL BLOOD THERAPEUTICS IN, MRTX, INCY, ASND 13F-HR 11/14/2022 000185565522000011
Q2 2022 23 501,530 LEGN, GLOBAL BLOOD THERAPEUTICS IN, MRTX, SRRA 13F-HR 8/15/2022 000185565522000008
Q1 2022 25 378,175 ASND, GLOBAL BLOOD THERAPEUTICS IN, ARVN, LEGN 13F-HR 5/16/2022 000185565522000006
Q4 2021 24 350,154 MRTX, ASND, ZNTL, VRDN 13F-HR 2/14/2022 000185565522000004